"Designing Growth Strategies is in our DNA"

Breast Cancer Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy, and Immunotherapy), By Cancer Type (Hormone Receptor, and HER2+), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2020-2027

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI100163

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Breast Cancer, By Key Countries/Regions, 2019
    2. Regulatory Scenario by Key Regions
    3. Overview of Current Advances in R&D for Breast Cancer Therapeutics
    4. Key Industry Developments
    5. New Product Launches
  5. Global Breast Cancer Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapy
      1. Targeted Therapy
        1. Abemaciclib
        2. Ado-Trastuzumab Emtansine
        3. Everolimus
        4. Trastuzumab
        5. Ribociclib
        6. Palbociclib
        7. Pertuzumab
        8. Olaparib
        9. Others
      2. Hormonal Therapy
        1. Selective Estrogen Receptor Modulators (SERMs)
        2. Aromatase Inhibitors
        3. Estrogen Receptor Downregulators (ERDs)
      3. Chemotherapy
      4. Immunotherapy
    3. Market Analysis, Insights and Forecast – By Cancer Type
      1. Hormone Receptor
      2. HER+
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Breast Cancer Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Therapy
      1. Targeted Therapy
        1. Abemaciclib
        2. Ado-Trastuzumab Emtansine
        3. Everolimus
        4. Trastuzumab
        5. Ribociclib
        6. Palbociclib
        7. Pertuzumab
        8. Olaparib
        9. Others
      2. Hormonal Therapy
        1. Selective Estrogen Receptor Modulators (SERMs)
        2. Aromatase Inhibitors
        3. Estrogen Receptor Downregulators (ERDs)
      3. Chemotherapy
      4. Immunotherapy
    3. Market Analysis – By Cancer Type
      1. Hormone Receptor
      2. HER+
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Breast Cancer Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Therapy
      1. Targeted Therapy
        1. Abemaciclib
        2. Ado-Trastuzumab Emtansine
        3. Everolimus
        4. Trastuzumab
        5. Ribociclib
        6. Palbociclib
        7. Pertuzumab
        8. Olaparib
        9. Others
      2. Hormonal Therapy
        1. Selective Estrogen Receptor Modulators (SERMs)
        2. Aromatase Inhibitors
        3. Estrogen Receptor Downregulators (ERDs)
      3. Chemotherapy
      4. Immunotherapy
    3. Market Analysis – By Cancer Type
      1. Hormone Receptor
      2. HER+
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Breast Cancer Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Therapy
      1. Targeted Therapy
        1. Abemaciclib
        2. Ado-Trastuzumab Emtansine
        3. Everolimus
        4. Trastuzumab
        5. Ribociclib
        6. Palbociclib
        7. Pertuzumab
        8. Olaparib
        9. Others
      2. Hormonal Therapy
        1. Selective Estrogen Receptor Modulators (SERMs)
        2. Aromatase Inhibitors
        3. Estrogen Receptor Downregulators (ERDs)
      3. Chemotherapy
      4. Immunotherapy
    3. Market Analysis – By Cancer Type
      1. Hormone Receptor
      2. HER+
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Breast Cancer Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Therapy
      1. Targeted Therapy
        1. Abemaciclib
        2. Ado-Trastuzumab Emtansine
        3. Everolimus
        4. Trastuzumab
        5. Ribociclib
        6. Palbociclib
        7. Pertuzumab
        8. Olaparib
        9. Others
      2. Hormonal Therapy
        1. Selective Estrogen Receptor Modulators (SERMs)
        2. Aromatase Inhibitors
        3. Estrogen Receptor Downregulators (ERDs)
      3. Chemotherapy
      4. Immunotherapy
    3. Market Analysis – By Cancer Type
      1. Hormone Receptor
      2. HER+
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Breast Cancer Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Therapy
      1. Targeted Therapy
        1. Abemaciclib
        2. Ado-Trastuzumab Emtansine
        3. Everolimus
        4. Trastuzumab
        5. Ribociclib
        6. Palbociclib
        7. Pertuzumab
        8. Olaparib
        9. Others
      2. Hormonal Therapy
        1. Selective Estrogen Receptor Modulators (SERMs)
        2. Aromatase Inhibitors
        3. Estrogen Receptor Downregulators (ERDs)
      3. Chemotherapy
      4. Immunotherapy
    3. Market Analysis – By Cancer Type
      1. Hormone Receptor
      2. HER+
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2019)
    2. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based On Availability))
      1. Genentech (F. Hoffmann-La Roche Ltd)
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      2. Eli Lilly and Company
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      3. Novartis AG
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      4. AstraZeneca
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      5. Pfizer Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      6. Sanofi
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      7. Eisai Co. Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      8. Kyowa Kirin
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      9. Bristol Myers Squibb (Celgene Corporation)
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      10. Merck & Co., Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
Read Less

Figure 1: Global Breast Cancer Therapeutics Market Revenue Breakdown (USD billion, %) by Region, 2019 & 2027

Figure 2: Global Breast Cancer Therapeutics Market Value Share (%), By Therapy, 2019 & 2027

Figure 3: Global Breast Cancer Therapeutics Market Forecast (USD billion), by Targeted Therapy, 2016-2027

Figure 4: Global Breast Cancer Therapeutics Market Forecast (USD billion), by Hormonal Therapy, 2016-2027

Figure 5: Global Breast Cancer Therapeutics Market Forecast (USD billion), by Chemotherapy, 2016-2027

Figure 6: Global Breast Cancer Therapeutics Market Forecast (USD billion), by Immunotherapy, 2016-2027

Figure 7: Global Breast Cancer Therapeutics Market Value Share (%), By Cancer Type, 2019 & 2027

Figure 8: Global Breast Cancer Therapeutics Market Forecast (USD billion), by Hormone Receptor, 2016-2027

Figure 11: Global Breast Cancer Therapeutics Market Forecast (USD billion), by HER+, 2016-2027

Figure 12: Global Breast Cancer Therapeutics Market Value Share (%), by Distribution Channel, 2019 & 2027

Figure 13: Global Breast Cancer Therapeutics Market Forecast (USD billion), by Hospital Pharmacies, 2016-2027

Figure 14: Global Breast Cancer Therapeutics Market Forecast (USD billion), by Retail Pharmacies, 2016-2027

Figure 15: Global Breast Cancer Therapeutics Market Forecast (USD billion), by Online Pharmacies, 2016-2027

Figure 16: Global Breast Cancer Therapeutics Market Forecast (USD billion), by Others, 2016-2027

Figure 17: Global Breast Cancer Therapeutics Market Value (USD billion), by Region, 2019 & 2027

Figure 18: North America Breast Cancer Therapeutics Market Value (USD billion), By Therapy, 2019 & 2027

Figure 19: North America Breast Cancer Therapeutics Market Value Share (%), By Therapy, 2019

Figure 20: North America Breast Cancer Therapeutics Market Value (USD billion), By Cancer Type, 2019 & 2027

Figure 21: North America Breast Cancer Therapeutics Market Value Share (%), By Cancer Type, 2019

Figure 22: North America Breast Cancer Therapeutics Market Value (USD billion), by Distribution Channel, 2019 & 2027

Figure 23: North America Breast Cancer Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 24: North America Breast Cancer Therapeutics Market Value (USD billion), By Country, 2019 & 2027

Figure 25: North America Breast Cancer Therapeutics Market Value Share (%), By Country, 2019

Figure 26: Europe Breast Cancer Therapeutics Market Value (USD billion), By Therapy, 2019 & 2027

Figure 27: Europe Breast Cancer Therapeutics Market Value Share (%), By Therapy, 2019

Figure 28: Europe Breast Cancer Therapeutics Market Value (USD billion), By Cancer Type, 2019 & 2027

Figure 29: Europe Breast Cancer Therapeutics Market Value Share (%), By Cancer Type, 2019

Figure 30: Europe Breast Cancer Therapeutics Market Value (USD billion), by Distribution Channel, 2019 & 2027

Figure 31: Europe Breast Cancer Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 32: Europe Breast Cancer Therapeutics Market Value (USD billion), By Country/ Sub-region, 2019 & 2027

Figure 33: Europe Breast Cancer Therapeutics Market Value Share (%), By Country/ Sub-region, 2019

Figure 34: Asia Pacific Breast Cancer Therapeutics Market Value (USD billion), By Therapy, 2019 & 2027

Figure 35: Asia Pacific Breast Cancer Therapeutics Market Value Share (%), By Therapy, 2019

Figure 36: Asia Pacific Breast Cancer Therapeutics Market Value (USD billion), By Cancer Type, 2019 & 2027

Figure 37: Asia Pacific Breast Cancer Therapeutics Market Value Share (%), By Cancer Type, 2019

Figure 38: Asia Pacific Breast Cancer Therapeutics Market Value (USD billion), by Distribution Channel, 2019 & 2027

Figure 39: Asia Pacific Breast Cancer Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 40: Asia Pacific Breast Cancer Therapeutics Market Value (USD billion), By Country/ Sub-region, 2019 & 2027

Figure 41: Asia Pacific Breast Cancer Therapeutics Market Value Share (%), By Country/ Sub-region, 2019

Figure 42: Latin America Breast Cancer Therapeutics Market Value (USD billion), By Therapy, 2019 & 2027

Figure 43: Latin America Breast Cancer Therapeutics Market Value Share (%), By Therapy, 2019

Figure 44: Latin America Breast Cancer Therapeutics Market Value (USD billion), By Cancer Type, 2019 & 2027

Figure 45: Latin America Breast Cancer Therapeutics Market Value Share (%), By Cancer Type, 2019

Figure 46: Latin America Breast Cancer Therapeutics Market Value (USD billion), by Distribution Channel, 2019 & 2027

Figure 47: Latin America Breast Cancer Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 48: Latin America Breast Cancer Therapeutics Market Value (USD billion), By Country/ Sub-region, 2019 & 2027

Figure 49: Latin America Breast Cancer Therapeutics Market Value Share (%), By Country/ Sub-region, 2019

Figure 50: Middle East & Africa Breast Cancer Therapeutics Market Value (USD billion), By Therapy, 2019 & 2027

Figure 51: Middle East & Africa Breast Cancer Therapeutics Market Value Share (%), By Therapy, 2019

Figure 52: Middle East & Africa Breast Cancer Therapeutics Market Value (USD billion), By Cancer Type, 2019 & 2027

Figure 53: Middle East & Africa Breast Cancer Therapeutics Market Value Share (%), By Cancer Type, 2019

Figure 54: Middle East & Africa Breast Cancer Therapeutics Market Value (USD billion), by Distribution Channel, 2019 & 2027

Figure 55: Middle East & Africa Breast Cancer Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 56: Middle East & Africa Breast Cancer Therapeutics Market Value (USD billion), By Country/ Sub-region, 2019 & 2027

Figure 57: Middle East & Africa Breast Cancer Therapeutics Market Value Share (%), By Country/ Sub-region, 2019

Figure 58: Global Breast Cancer Therapeutics Market Share (%), By Company, 2019

Table 1:   Global Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Therapy, 2016-2027

Table 2:   Global Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Targeted Therapy, 2016-2027

Table 3:   Global Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Hormonal Therapy, 2016-2027

 Table 4:   Global Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Cancer Type, 2016-2027

 Table 5:   Global Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

 Table 6:   Global Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, by Region, 2016-2027

 Table 7:  North America Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Therapy, 2016-2027

Table 8:   North America Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Targeted Therapy, 2016-2027

Table 9:   North America Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Hormonal Therapy, 2016-2027

 Table 10:   North America Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Cancer Type, 2016-2027

 Table 11:   North America Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

 Table 12:   North America Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Country, 2016-2027

 Table 13:   Europe Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Therapy, 2016-2027

Table 14:   Europe Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Targeted Therapy, 2016-2027

Table 15:   Europe Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Hormonal Therapy, 2016-2027

 Table 16:   Europe Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Cancer Type, 2016-2027

Table 17:   Europe Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

 Table 18:   Europe Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2016-2027

 Table 19:   Asia Pacific Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Therapy, 2016-2027

Table 20:   Asia Pacific Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Targeted Therapy, 2016-2027

Table 21:   Asia Pacific Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Hormonal Therapy, 2016-2027

 Table 22:   Asia Pacific Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Cancer Type, 2016-2027

 Table 23:   Asia Pacific Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

 Table 24:   Asia Pacific Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2016-2027

 Table 25:   Latin America Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Therapy, 2016-2027

Table 26:   Latin America Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Targeted Therapy, 2016-2027

Table 27:   Latin America Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Hormonal Therapy, 2016-2027

 Table 28:   Latin America Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Cancer Type, 2016-2027

 Table 29:   Latin America Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

 Table 30:   Latin America Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2016-2027

 Table 31:   Middle East & Africa Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Therapy, 2016-2027

Table 32:   Middle East & Africa Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Targeted Therapy, 2016-2027

Table 33:   Middle East & Africa Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Hormonal Therapy, 2016-2027

 Table 34:   Middle East & Africa Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Cancer Type, 2016-2027

 Table 35:   Middle East & Africa Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

 Table 36:   Middle East & Africa Breast Cancer Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2016-2027

Breast Cancer Therapeutics Market Size, Share and Global Industry Trend Forecast till 2027
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Consulting Services
    How will you benefit from our consulting services ?